Free tool
Stocks listed on Copenhagen
We cover 21 companies listed on Copenhagen. The median market value in the group is $2.13B. Across the group, the median move over the past trading day is +2.44%. 62% of the 21 with a 200-day average trade above it. Price change over the past year runs from −28.3% to +23.8% across the middle 80 percent of the group, with a median of −6.9%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Table
21 of 568 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| NOVO-B.CO | Novo Nordisk A/S | $210.20B | Mega cap | −11.26% |
| GMAB.CO | Genmab A/S | $20.69B | Large cap | +36.19% |
| COLO-B.CO | Coloplast A/S | $15.96B | Large cap | −20.60% |
| DEMANT.CO | Demant A/S | $9.36B | Mid cap | +17.12% |
| ALK-B.CO | ALK-Abelló A/S | $7.26B | Mid cap | +5.09% |
| HLUN-B.CO | H. Lundbeck A/S | $6.47B | Mid cap | +8.99% |
| HLUN-A.CO | H. Lundbeck A/S | $6.40B | Mid cap | +29.71% |
| ZEAL.CO | Zealand Pharma A/S | $3.34B | Mid cap | −25.94% |
| AMBU-B.CO | Ambu A/S | $2.69B | Mid cap | −19.13% |
| BAVA.CO | Bavarian Nordic A/S | $2.51B | Mid cap | −7.97% |
| GN.CO | GN Store Nord A/S | $2.13B | Mid cap | −18.50% |
| EMBLA.CO | Embla Medical hf. | $1.93B | Small cap | −6.94% |
| CHEMM.CO | ChemoMetec A/S | $1.33B | Small cap | −3.94% |
| GUBRA.CO | Gubra A/S | $1.02B | Small cap | +4.79% |
| BIOPOR.CO | BioPorto A/S | $93.40M | Micro cap | −3.13% |
| PEG.CO | Pharma Equity Group A/S | $16.84M | Micro cap | −38.85% |
| VIRO.CO | ViroGates A/S | $15.77M | Micro cap | −1.00% |
| SMSMED.CO | Scandinavian Medical Solutions A/S | $12.36M | Micro cap | −28.33% |
| STENO.CO | Stenocare A/S | $6.36M | Micro cap | −22.91% |
| STRAP.CO | Strategic Partners A/S | $5.82M | Micro cap | −28.50% |
| MONSO.CO | Monsenso A/S | $3.14M | Micro cap | +23.81% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.